This article was published over 10 years ago and may not reflect current information. If you have questions about its accuracy, please refer to our Contact Us page.

A global first: guidance for assessing safety of Enterococcus faecium in animal feed

The European Food Safety Authority (EFSA) has developed pioneering guidance for the safety assessment of one of the most common probiotics used in animal feed, Enterococcus faecium. The guidance provides a new methodology for distinguishing between safe and potentially harmful strains of E. faecium in animal nutrition. It is intended for use by feed additive Product intentionally added to animal feed to improve: i) the quality of the feeds ii) the quality of the food products obtained from animals; iii) animal performance and health producers submitting applications to EFSA for safety assessment.

Enterococci are well-known bacteria and are found in abundance in the gastrointestinal tract of both animals and humans. They are often used in the production of feed additives as a probiotic to prevent diarrhoea or to improve growth in animals.  The efficacy How well something works in relation to predefined standards or expectations of the feed additives is assessed by EFSA’s experts together with their safety. Over the last 20 years, certain antibiotic-resistant, infectious strains of enterococci, including E.faecium, have been identified in hospital patients. Outside healthcare settings, enterococci very rarely present a risk of infection for humans.

The development of new scientific approaches, particularly in the area of genomics, has allowed a far better understanding of why some strains of E. faecium present public health problems. Until now, for E. faecium-based additives to be deemed safe by EFSA, feed additive producers needed to demonstrate the absence of a number of genetic markers associated with the virulence The degree or ability of a disease-causing organism (e.g. a bacterium, virus or parasite) to cause disease of these bacteria. In this new EFSA guidance document, a practical methodology is given to differentiate between safe strains and the potentially harmful clinical strains of E. faecium, based on the bacteria’s susceptibility to the antibiotic ampicillin and the absence of three genetic markers associated with virulence. In practice, this will mean a significant reduction in the number of tests and data that producers must submit to EFSA as part of their applications for the authorisation of E. faecium-basedfeed additives. It also increases clarity for applicants in terms of the criteria EFSA uses to assess the safety of their products.

The guidance document was developed over the last year by EFSA’s Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) in co-operation with the leading international experts in this area and was subject to a public consultation on EFSA's website.

How to contact us

EFSA Media Relations Office

Tel. +39 0521 036 149

E-mail: press [at] efsa.europa.eu (Press[at]efsa[dot]europa[dot]eu)

(Only if you are a member of the press)

Ask a Question Service

You have a question about EFSA’s work? Contact our Ask a Question service!

Ask a Question Service